5/13/24 17:04 | 5/9/24 | ELDN | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P.d | 0 | 0.00 | 0 | 1,928 | | 220 | D | | | | | | | | | | | | | | |
5/9/23 20:25 | 5/5/23 | ELDN | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P.d | 0 | 0.00 | 0 | 1,979 | | 145 | D | | | | | | | | | | | | | | |
11/23/22 16:05 | 11/23/22 | ELDN | Health | Drug | Pharmaceutical Preparations | Perrin Steven | CA | DO | P | P | 3 | 2.60 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
12/21/21 16:05 | 12/20/21 | ELDN | Health | Drug | Pharmaceutical Preparations | Gros David-Alexandre C | CA | DO | CEO | P | 9 | 4.48 | 0 | 2 | 29 | 9 | D | | | | | | | | | | | | | | |
8/19/21 16:05 | 8/17/21 | ELDN | Health | Drug | Pharmaceutical Preparations | Gros David-Alexandre C | CA | DO | CEO | P | 25 | 6.21 | 0 | 4 | 133 | 7 | D | | | | | | | | | | | | | | |
6/14/21 17:24 | 6/11/21 | ELDN | Health | Drug | Pharmaceutical Preparations | Little Paul Sean | CA | O | CFO | P | 89 | 8.87 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
6/10/21 17:25 | 6/9/21 | ELDN | Health | Drug | Pharmaceutical Preparations | Gros David-Alexandre C | CA | DO | CEO | P | 24 | 8.01 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
11/6/20 18:46 | 10/30/20 | NVUS | Health | Drug | Pharmaceutical Preparations | Logos Global Management LP | CA | T | | P | 2,342 | 25.44 | 0 | 92 | 70 | 224 | I | | | | | | | | | | | | | | |
5/6/19 17:30 | 5/2/19 | NVUS | Health | Drug | Pharmaceutical Preparations | Orbimed Israel Gp Ltd. | L3 | DT | | P.d | 2,003 | 3.10 | 0 | 646 | 25 | 3,183 | I | | | | | | | | | | | | | | |
5/6/19 17:28 | 5/2/19 | NVUS | Health | Drug | Pharmaceutical Preparations | Chimovits Erez | CA | D | | P.d | 2,003 | 3.10 | 0 | 646 | 25 | 3,183 | I | | | | | | | | | | | | | | |
9/13/18 20:00 | 9/11/18 | NVUS | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | P | P.m | 161 | 4.78 | 0 | 34 | 74 | 79 | D | | | | | | | | | | | | | | |
9/7/18 20:00 | 9/5/18 | NVUS | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | P | P | 3 | 3.97 | 0 | 1 | 2 | 45 | I | | | | | | | | | | | | | | |
5/11/17 20:36 | 5/10/17 | NVUS | Health | Drug | Pharmaceutical Preparations | Flesher Gregory J. | CA | DO | CEO | P | 589 | 9.99 | 0 | 59 | 104 | 116 | D | -94 | -92 | -34 | -32 | -27 | -5 | 0 | 3 | -3 | | | | | |
5/11/17 20:33 | 5/10/17 | NVUS | Health | Drug | Pharmaceutical Preparations | Turkel Catherine C. | CA | O | Chief De | P | 111 | 9.99 | 0 | 11 | 83 | 25 | D | -94 | -92 | -34 | -32 | -27 | -5 | 0 | 3 | -3 | | | | | |
5/11/17 20:30 | 5/10/17 | NVUS | Health | Drug | Pharmaceutical Preparations | Ocampo Christine | CA | O | See Rema | P | 100 | 9.99 | 0 | 10 | 86 | 22 | D | -94 | -92 | -34 | -32 | -27 | -5 | 0 | 3 | -3 | | | | | |
3/15/16 16:02 | 3/15/16 | TKAI | Health | Drug | Pharmaceutical Preparations | Buckley Stephen Jr. | MA | D | | P | 46 | 5.74 | 0 | 8 | 267 | 11 | D | | -55 | -52 | -41 | 1 | -1 | -12 | -2 | -4 | -4 | 33 | 16 | -78 | -81 |
11/12/15 09:06 | 11/11/15 | TKAI | Health | Drug | Pharmaceutical Preparations | Buckley Stephen Jr. | MA | D | | P | 34 | 11.25 | 2 | 3 | New | 3 | D | | -29 | -5 | 0 | 10 | 8 | 6 | -2 | -1 | -2 | -13 | -46 | -41 | -91 |
9/24/14 17:54 | 9/22/14 | TKAI | Health | Drug | Pharmaceutical Preparations | Satter Muneer A | MA | T | | P.d | 2,250 | 15.00 | 33 | 150 | 9 | 1,772 | I | | | | | | | | -14 | 1 | -4 | -15 | -5 | -16 | -17 |
9/24/14 17:52 | 9/22/14 | TKAI | Health | Drug | Pharmaceutical Preparations | Apple Tree Partners II - Annex, L.P. | NJ | DT | | P.d | 3,563 | 15.00 | 33 | 238 | 7 | 3,568 | D | | | | | | | | -14 | 1 | -4 | -15 | -5 | -16 | -17 |
9/24/14 17:44 | 9/22/14 | TKAI | Health | Drug | Pharmaceutical Preparations | Harrison Seth Loring | MA | DT | | P.d | 5,438 | 15.00 | 33 | 363 | 5 | 8,125 | I | | | | | | | | -14 | 1 | -4 | -15 | -5 | -16 | -17 |
9/24/14 17:42 | 9/22/14 | TKAI | Health | Drug | Pharmaceutical Preparations | Novartis Bioventures Ltd | D0 | T | | P.d | 4,875 | 15.00 | 33 | 325 | 8 | 4,644 | D | | | | | | | | -14 | 1 | -4 | -15 | -5 | -16 | -17 |